New crystalline form of aripiprazole characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C

The present invention provides a novel crystalline form N of aripiprazole, a pharmaceutical composition thereof, and the use of the crystalline form N in the preparation of a medicament for the treatment of central nervous system disorders (particularly schizophrenia). This invention is characterize...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JIANG, WEI-MING, SUN, YUN-ZHE, LIN, CHENG-GANG, LIU, FEI, GUI, LI, ZHAO, XIN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JIANG, WEI-MING
SUN, YUN-ZHE
LIN, CHENG-GANG
LIU, FEI
GUI, LI
ZHAO, XIN
description The present invention provides a novel crystalline form N of aripiprazole, a pharmaceutical composition thereof, and the use of the crystalline form N in the preparation of a medicament for the treatment of central nervous system disorders (particularly schizophrenia). This invention is characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C. Also, the crystalline form has a powder X-ray diffraction spectrum which has the same peak position as that of the powder X-ray diffraction pattern shown in Figure 1.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW201730178A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW201730178A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW201730178A3</originalsourceid><addsrcrecordid>eNqNTbtOA0EMvIYCAf9gPgDB5UDQohCgoopEGVl7c9yKfclrBJdvp8C5RKKgobBHHs_juPl-wSc5mapyCD6BhiyR8kAsvvgivM0B5EYWdgrxW_TkE-nIagt_rSPX-VEkF4hOv9LeDwMEST0HGmFsdZzIkOfTpzcSVuzab-hh9UTLy2hdu0TTIfXZYiR6RwX8vjcqotWwfsjs42K9Xz5aTJioXRxyzN-TC7mCNFPbXe_p0-Zo4FBxdsCT5vxxtV4-X6DkDWphhwTdrF8XV-1tZ3N33_1H8wMCoXMC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>New crystalline form of aripiprazole characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C</title><source>esp@cenet</source><creator>JIANG, WEI-MING ; SUN, YUN-ZHE ; LIN, CHENG-GANG ; LIU, FEI ; GUI, LI ; ZHAO, XIN</creator><creatorcontrib>JIANG, WEI-MING ; SUN, YUN-ZHE ; LIN, CHENG-GANG ; LIU, FEI ; GUI, LI ; ZHAO, XIN</creatorcontrib><description>The present invention provides a novel crystalline form N of aripiprazole, a pharmaceutical composition thereof, and the use of the crystalline form N in the preparation of a medicament for the treatment of central nervous system disorders (particularly schizophrenia). This invention is characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C. Also, the crystalline form has a powder X-ray diffraction spectrum which has the same peak position as that of the powder X-ray diffraction pattern shown in Figure 1.</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170901&amp;DB=EPODOC&amp;CC=TW&amp;NR=201730178A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170901&amp;DB=EPODOC&amp;CC=TW&amp;NR=201730178A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JIANG, WEI-MING</creatorcontrib><creatorcontrib>SUN, YUN-ZHE</creatorcontrib><creatorcontrib>LIN, CHENG-GANG</creatorcontrib><creatorcontrib>LIU, FEI</creatorcontrib><creatorcontrib>GUI, LI</creatorcontrib><creatorcontrib>ZHAO, XIN</creatorcontrib><title>New crystalline form of aripiprazole characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C</title><description>The present invention provides a novel crystalline form N of aripiprazole, a pharmaceutical composition thereof, and the use of the crystalline form N in the preparation of a medicament for the treatment of central nervous system disorders (particularly schizophrenia). This invention is characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C. Also, the crystalline form has a powder X-ray diffraction spectrum which has the same peak position as that of the powder X-ray diffraction pattern shown in Figure 1.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNTbtOA0EMvIYCAf9gPgDB5UDQohCgoopEGVl7c9yKfclrBJdvp8C5RKKgobBHHs_juPl-wSc5mapyCD6BhiyR8kAsvvgivM0B5EYWdgrxW_TkE-nIagt_rSPX-VEkF4hOv9LeDwMEST0HGmFsdZzIkOfTpzcSVuzab-hh9UTLy2hdu0TTIfXZYiR6RwX8vjcqotWwfsjs42K9Xz5aTJioXRxyzN-TC7mCNFPbXe_p0-Zo4FBxdsCT5vxxtV4-X6DkDWphhwTdrF8XV-1tZ3N33_1H8wMCoXMC</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>JIANG, WEI-MING</creator><creator>SUN, YUN-ZHE</creator><creator>LIN, CHENG-GANG</creator><creator>LIU, FEI</creator><creator>GUI, LI</creator><creator>ZHAO, XIN</creator><scope>EVB</scope></search><sort><creationdate>20170901</creationdate><title>New crystalline form of aripiprazole characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C</title><author>JIANG, WEI-MING ; SUN, YUN-ZHE ; LIN, CHENG-GANG ; LIU, FEI ; GUI, LI ; ZHAO, XIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW201730178A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JIANG, WEI-MING</creatorcontrib><creatorcontrib>SUN, YUN-ZHE</creatorcontrib><creatorcontrib>LIN, CHENG-GANG</creatorcontrib><creatorcontrib>LIU, FEI</creatorcontrib><creatorcontrib>GUI, LI</creatorcontrib><creatorcontrib>ZHAO, XIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JIANG, WEI-MING</au><au>SUN, YUN-ZHE</au><au>LIN, CHENG-GANG</au><au>LIU, FEI</au><au>GUI, LI</au><au>ZHAO, XIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>New crystalline form of aripiprazole characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C</title><date>2017-09-01</date><risdate>2017</risdate><abstract>The present invention provides a novel crystalline form N of aripiprazole, a pharmaceutical composition thereof, and the use of the crystalline form N in the preparation of a medicament for the treatment of central nervous system disorders (particularly schizophrenia). This invention is characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C. Also, the crystalline form has a powder X-ray diffraction spectrum which has the same peak position as that of the powder X-ray diffraction pattern shown in Figure 1.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW201730178A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title New crystalline form of aripiprazole characterized in that the crystalline form has the property that the differential heat scan at a heating rate of 5 DEG C/min has an endothermic peak at a temperature of approximately 125 DEG C and close to 134 DEG C
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A04%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JIANG,%20WEI-MING&rft.date=2017-09-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW201730178A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true